Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 41Breast Neoplasms 40Lung Neoplasms 25Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Uterine Cervical Neoplasms 13Prostatic Neoplasms 13Pancreatic Neoplasms 11Head and Neck Neoplasms 11Carcinoma, Hepatocellular 11Melanoma 10Ovarian Neoplasms 9Neoplastic Cells, Circulating 7Myelodysplastic Syndromes 7Glioma 7Esophageal Neoplasms 7Endometrial Neoplasms 7Brain Neoplasms 7Sarcoma 6Multiple Myeloma 6Gastrointestinal Neoplasms 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Disease 5Colonic Neoplasms 5Uveal Melanoma 4Skin Neoplasms 4Neoplasm, Residual 4

Interventions

fluoroazomycin arabinoside 2Propofol 2pimonidazole 1Tirapazamine 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Magnetic Resonance Imaging 1Ketamine 1Ethiodized Oil 1Dexmedetomidine 1Blood Specimen Collection 1Alfentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypoxia × Blood Specimen Collection × 1 year × Clear all
NCT01181375 2026-03-05

Predictive Assays In Cervix Cancer

University Health Network, Toronto

Phase NA Active not recruiting
500 enrolled
Gynecologic

Hypoxia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡